This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the supply of Olopatadine HCL 0.1% eye drops in 5ml containers. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. No set-aside designation was used. This contract appears to be under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/28/25, 10:50 AM